Table of Contents
Analgesics in the Netherlands
Euromonitor International
May 2009
List of Contents and Tables
Executive Summary
Prevention and
Innovation Trends Drive Demand in 2008
Moderate Impact of More Open
Distribution Through Supermarkets
Continuing Concentration Trend Among
Larger Manufacturers
Online Sales Gradually Increasing
Dutch Quest for
Prevention To Drive Future Demand
Key Trends and Developments
Lower
Economic Expansion Envisaged
Health and Prevention Trends Strongly
Influence OTC Healthcare Performance
Increasing Ageing Population
Influenced by Quest for Longevity
Dutch Consumers Become More Interested
in Fitness and Sports
Legislative Changes Allow Wider Distribution
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical
Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
Market
Data
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table
4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC
Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand
Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector
2003-2008
Table 8 Sales of OTC Healthcare by Distribution Format: %
Analysis 2003-2008
Table 9 Sales of OTC Healthcare by Sector and
Distribution Format: % Analysis 2008
Table 10 Forecast Sales of OTC
Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of OTC
Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC
Registration and Classification
Labelling and Patient Information
Advertising
Distribution
Vitamins & Dietary Supplements Registration
and Classification
EU Legislation
Self-medication and Preventative
Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches
2005-2008
Definitions
Summary 2 Research Sources
Bional Pharma
BV
Strategic Direction
Key Facts
Summary 3 Bional Pharma BV: Key
Facts
Summary 4 Bional Pharma BV: Operational Indicators
Company
Background
Production
Competitive Positioning
Summary 5 Bional
Pharma BV: Competitive Position 2008
Caresse Cosmetics BV
Strategic
Direction
Key Facts
Summary 6 Caresse Cosmetics BV: Key Facts
Summary 7 Caresse Cosmetics BV: Operational Indicators
Company
Background
Production
Competitive Positioning
Distributie Care
BV
Strategic Direction
Key Facts
Summary 8 Distributie Care BV:
Key Facts
Company Background
Production
Competitive
Positioning
Summary 9 Distributie Care BV: Competitive Position 2008
Ingroma BV
Strategic Direction
Summary 10 Ingroma BV: Key Facts
Summary 11 Ingroma BV: Operational Indicators
Company Background
Production
Competitive Positioning
Vemedia BV
Strategic
Direction
Key Facts
Summary 12 Vemedia BV: Key Facts
Summary 13
Vemedia BV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 14 Vemedia BV: Competitive Position
2008
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 12 Sales of Analgesics by Subsector: Value
2003-2008
Table 13 Sales of Analgesics by Subsector: % Value Growth
2003-2008
Table 14 Herbal vs Standard Topical Analgesics 2003-2008
Table 15 Topical Analgesics by Format: % Value Breakdown 2004-2008
Table
16 Analgesics Company Shares by Value 2004-2008
Table 17 Analgesics Brand
Shares by Value 2005-2008
Table 18 Forecast Sales of Analgesics by
Subsector: Value 2008-2013
Table 19 Forecast Sales of Analgesics by
Subsector: % Value Growth 2008-2013
| 
View Cart
